$SPOM SPO GLOBAL POISED TO BREAKOUT IN 2017 SPOM
Post# of 44860
Feb 13, 2017
OTC Disclosure & News Service
Woburn, MA -
SPO GLOBAL POISED TO BREAKOUT IN 2017
To All Shareholders:
I would first like to address to all our shareholders an important issue regarding the current share price and market valuation of our company.
During the last weeks, I have been getting numerous calls and emails from shareholders expressing support for our company while naturally at the same time having concerns at the current share price.
Over the last months, we have stated in many press releases that we believe our company is undervalued based upon an independent valuation and on the M & A market.
We recently entered into an agreement with Blackbridge Growth Fund and filed a Form 1-A; Regulation A Offering Statement for an offering of $500,000. We are awaiting approval from the SEC on this.
The funds from this offering will be used to accelerate our growth and underpin the capital requirements of the company as we increase our marketing and win more enterprise customers.
The company owns all its software IP and has already invested significant capital into research and development of our software.
We have major enterprise customers deploying our StressTester & Sentinel applications, spanning various vertical market sectors, including Government, Large Corporations and Educational establishments.
Our business future looks bright with large opportunities on the near horizon, and the share price we envisage, will reflect this.
We thank all our loyal shareholders for staying with us.
Owen Dukes
This shareholder letter contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry, and that reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, expectations regarding the successful expansion of our product base, profitability, market acceptance of our products and new product applications, timing of new product launches, product performance, size of prospective markets, marketing strategies, success of our restructured operations and plans, our ability to generate fees or raise
capital to support our business operations and plan, the sufficiency and availability of working capital, changes in economic conditions generally and in more specifically, the introduction of competing products, changes in our operating strategy or development plans, patent protection for our products and technologies, changes in economic conditions generally and in more specifically, in the markets we operate, changes in technology, legislative or regulatory changes that affect us. We undertake no obligation to revise or update any forward-looking statement for any reason.
Copyright © 2017 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
http://www.otcmarkets.com/stock/SPOM/news/SPO...93&b=y
Trade Free for 60 Days & Get Up to $600. Join E*TRADE Today!Advertisement